Published in Nature on January 21, 2016
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. Cell (2016) 1.36
Reconstructing metastatic seeding patterns of human cancers. Nat Commun (2017) 0.92
Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer (2017) 0.87
The Multiple Roles of Exosomes in Metastasis. Cancer Genomics Proteomics (2016) 0.81
Cancer Cell Colonisation in the Bone Microenvironment. Int J Mol Sci (2016) 0.81
Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
Determinants of metastatic competency in colorectal cancer. Mol Oncol (2017) 0.80
Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer. Oncotarget (2016) 0.80
3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Dis Model Mech (2017) 0.78
Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci Rep (2016) 0.77
Cell and Signal Components of the Microenvironment of Bone Metastasis Are Affected by Hypoxia. Int J Mol Sci (2016) 0.77
Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study. Clin Med Insights Oncol (2016) 0.77
Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research. Anal Cell Pathol (Amst) (2016) 0.76
Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma. Cell Death Dis (2017) 0.76
Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix. Mol Biol Cell (2017) 0.76
Macrophages as Key Drivers of Cancer Progression and Metastasis. Mediators Inflamm (2017) 0.75
Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells. Sci Rep (2017) 0.75
The role of osteoblasts in bone metastasis. J Bone Oncol (2016) 0.75
Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. Trends Mol Med (2017) 0.75
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75
RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis. Biomed Res Int (2017) 0.75
Orchestration of the crosstalk between astrocytes and cancer cells affects the treatment and prognosis of lung cancer sufferers with brain metastasis. J Thorac Dis (2016) 0.75
Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol (2017) 0.75
Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review. Medicine (Baltimore) (2017) 0.75
Arresting supporters: targeting neutrophils in metastasis. Cell Res (2016) 0.75
Immune Regulation of the Metastatic Process: Implications for Therapy. Adv Cancer Res (2016) 0.75
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis. Onco Targets Ther (2017) 0.75
In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone. Int J Mol Sci (2016) 0.75
Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis. Oncotarget (2017) 0.75
Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer (2017) 0.75
TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts. Oncotarget (2016) 0.75
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection. Front Pharmacol (2017) 0.75
Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2. Cancer Cell Int (2017) 0.75
Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis. JCI Insight (2016) 0.75
Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis. J Hematol Oncol (2017) 0.75
Epigenetic determinants of metastasis. Mol Oncol (2016) 0.75
Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. Oncogene (2017) 0.75
The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies. Oncotarget (2017) 0.75
Novel "Elements" of Immune Suppression within the Tumor Microenvironment. Cancer Immunol Res (2017) 0.75
GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment. Cancer Res (2017) 0.75
Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells. Transl Cancer Res (2016) 0.75
Inside the Cell: Integrins as New Governors of Nuclear Alterations? Cancers (Basel) (2017) 0.75
Exo70 is an independent prognostic factor in colon cancer. Sci Rep (2017) 0.75
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development. Front Immunol (2017) 0.75
Mouse models of metastasis: progress and prospects. Dis Model Mech (2017) 0.75
Tumor cells interact with red blood cells via galectin-4 - a short report. Cell Oncol (Dordr) (2017) 0.75
Intravital imaging of metastasis in adult Zebrafish. BMC Cancer (2017) 0.75
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cell Oncol (Dordr) (2017) 0.75
Tumor cell dormancy. Mol Oncol (2016) 0.75
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
A perspective on cancer cell metastasis. Science (2011) 13.31
Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Clonal evolution in cancer. Nature (2012) 11.07
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature (2012) 10.39
Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell (2008) 9.92
Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol (2009) 9.87
A restricted cell population propagates glioblastoma growth after chemotherapy. Nature (2012) 8.88
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 8.62
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Lysyl oxidase is essential for hypoxia-induced metastasis. Nature (2006) 8.28
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med (2015) 7.51
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature (2007) 7.05
Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2011) 6.94
A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med (2005) 6.86
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell (2009) 6.66
Tumor self-seeding by circulating cancer cells. Cell (2009) 6.66
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science (2012) 6.55
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. Cell (2015) 6.38
Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell (2011) 6.21
Autonomic nerve development contributes to prostate cancer progression. Science (2013) 6.11
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Parallel progression of primary tumours and metastases. Nat Rev Cancer (2009) 5.55
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest (1999) 5.30
Integrative clinical genomics of advanced prostate cancer. Cell (2015) 5.29
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24
Defining the mode of tumour growth by clonal analysis. Nature (2012) 5.02
A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell (2012) 4.89
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 4.68
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (2015) 4.58
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell (2014) 4.53
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014) 4.44
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest (2011) 4.43
Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol (1998) 4.41
Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol (2009) 4.39
Evolution of the cancer stem cell model. Cell Stem Cell (2014) 4.38
Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med (2000) 4.36
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature (2015) 4.18
Tumour exosome integrins determine organotropic metastasis. Nature (2015) 4.09
Cancer to bone: a fatal attraction. Nat Rev Cancer (2011) 4.08
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol (2015) 4.08
The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96
Real-time imaging reveals the single steps of brain metastasis formation. Nat Med (2009) 3.95
Oxidative stress inhibits distant metastasis by human melanoma cells. Nature (2015) 3.87
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med (2011) 3.82
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature (2015) 3.77
Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell (2013) 3.74
The evolutionary history of lethal metastatic prostate cancer. Nature (2015) 3.59
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev (2008) 3.50
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol (2004) 3.47
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature (2014) 3.45
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest (2010) 3.41
Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas. Cancer Cell (2012) 3.37
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell (2013) 3.33
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell (2011) 3.32
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature (2015) 3.24
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med (2012) 3.21
Therapy-induced tumour secretomes promote resistance and tumour progression. Nature (2015) 3.07
Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell (2014) 3.04
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med (2012) 2.95
DNA damage-mediated induction of a chemoresistant niche. Cell (2010) 2.94
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell (2012) 2.94
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature (2014) 2.91
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell (2012) 2.84
Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature (2014) 2.75
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med (2001) 2.74
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
The cytoskeleton and cancer. Cancer Metastasis Rev (2009) 2.70
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med (2012) 2.66
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65
Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell (2011) 2.64
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev (2009) 2.59
Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res (2000) 2.58
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell (2015) 2.52
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature (2014) 2.52
Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell (2012) 2.50
Origins of metastatic traits. Cancer Cell (2013) 2.49